Macular degeneration is very common and affects an estimated 19.8 million people in the United States. Approximately one in 10 Americans age 50 and older have an early form of the disease and as many ...

Retinitis pigmentosa is a relatively rare genetic disorder (affecting 1 in 3,500 people), while age-related macular degeneration affects 7–8% of the population, and its incidence increases with age.

The company says that in pre-clinical tests performed on 30 people with macular degeneration, all of the participants experienced a reading speed increase of at least 50% when using the glasses.

"Physical activity has been investigated as a preventive tool to defeat the main biological features of Alzheimer's disease: pathological amyloid protein plaques, tau tangles, myelin degeneration ...

In parallel, we continue to advance our preclinical and research pipeline with key programs, including ADP037-ABC, a brain-penetrant anti-amyloid beta antibody for Alzheimer’s disease ...

Macular degeneration causes vision loss and primarily affects people age 65 and older. The condition affects the macula, the sensitive part of the retina responsible for sharp, central vision. There ...

Cardiac amyloidosis used to be considered an ultra-rare disease with no treatment options. No longer. Advances in noninvasive testing have led to greater awareness, earlier diagnosis and improved ...

Cumulative activation of mechanisms and structural damage ultimately result in cytoskeleton fragmentation and axon degeneration. Although there is a general notion that the development of dystrophic ...

We discuss how protein immobilization can occur through a highly choreographed amyloidogenic program that converts the nucleolus into a large fibrous organelle with amyloid-like characteristics called ...